AI Science Tracker
EN

Department of Medical Radiation Engineering, Shahid Beheshti University, Tehran, Iran

1 discovery from 2025

Discoveries

Cross-regional radiomics: a novel framework for relationship-based feature extraction with validation in Parkinson's disease motor subtyping.

Source check: Source checked. Not independent scientific confirmation.

Finding: T1 MRI from 140 early-stage Parkinson patients is assessed across six classifiers and five-fold validation; motor-circuit features improve subtype discrimination. Published in BioData Mining.

Technology: Cross-regional radiomics extracts brain-network relationships to classify Parkinson motor subtypes.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Cross-regional radiomics extracts brain-network relationships to classify Parkinson motor subtypes.
Test and result
Limited early-stage cohort and no broad external-site validation restrict generalization.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/41024049 · https://pmc.ncbi.nlm.nih.gov/articles/PMC12482597/ · https://pubmed.ncbi.nlm.nih.gov/41024049/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.